NASDAQ:AFMD
Affimed N.V. Stock News
$4.88
-0.470 (-8.79%)
At Close: Apr 24, 2024
Affimed Announces Presentations of Clinical Data from AFM13 Phase 2 REDIRECT and Pre-clinical Data Demonstrating CD16A Shedding Facilitates Repetitive Targeting of Tumor Cells by AFM13-armed NK Cells at the Annual Meeting of the American Association for Cancer Research
08:30pm, Tuesday, 14'th Mar 2023 GlobeNewswire Inc.
HEIDELBERG, Germany, March 14, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer,
Ikena Oncology, Inc. (IKNA) Reports Q4 Loss, Tops Revenue Estimates
12:15pm, Tuesday, 14'th Mar 2023 Zacks Investment Research
Ikena Oncology, Inc. (IKNA) delivered earnings and revenue surprises of 26.42% and 67.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock
AbCheck Announces Successful Completion of Research and Development Under Grant to Develop a Novel Microfluidics Technology for Functional Antibody Discovery
10:00am, Thursday, 09'th Mar 2023 GlobeNewswire Inc.
PLZEN, Czech Republic, March 09, 2023 (GLOBE NEWSWIRE) -- AbCheck s.r.o., a technology company delivering disruptive antibody discovery and development solutions for challenging targets, announced t
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates
10:45pm, Monday, 06'th Mar 2023 Zacks Investment Research
Anika (ANIK) delivered earnings and revenue surprises of -54.55% and 3.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Tops Revenue Estimates
12:15am, Wednesday, 01'st Mar 2023 Zacks Investment Research
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 13.46% and 166.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto
Affimed to Participate in Fireside Chat at the H.C. Wainwright Cell Therapy Virtual Conference
11:30am, Wednesday, 22'nd Feb 2023 GlobeNewswire Inc.
HEIDELBERG, Germany, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, a
Affimed to Participate in Fireside Chat at the H.C. Wainwright Cell Therapy Virtual Conference
06:30am, Wednesday, 22'nd Feb 2023
HEIDELBERG, Germany, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, ann
AbCheck Announces Collaboration to Apply Microfluidics Technology to the Discovery of Antibodies Against Challenging Therapeutic Neurology Target
10:00am, Tuesday, 21'st Feb 2023 GlobeNewswire Inc.
PLZEN, Czech Republic, Feb. 21, 2023 (GLOBE NEWSWIRE) -- AbCheck s.r.o., a technology company delivering disruptive antibody discovery and development solutions for challenging targets, announced to
Affimed to Present at the SVB Securities 2023 Global Biopharma Conference
11:30am, Wednesday, 08'th Feb 2023 GlobeNewswire Inc.
HEIDELBERG, Germany, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, a
Affimed to Present at the SVB Securities 2023 Global Biopharma Conference
06:30am, Wednesday, 08'th Feb 2023
HEIDELBERG, Germany, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, ann
7 Cheap But Risky Biotech Stocks
01:58pm, Wednesday, 18'th Jan 2023
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF drop nearly 50%.
UnitedHealth's (UNH) UnitedHealthcare Unit to Aid Q4 Earnings?
01:43pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
An increase in the number of people served in the commercial domestic business of UnitedHealth's (UNH) UnitedHealthcare segment is likely to boost fourth-quarter results.
UnitedHealth (UNH) to Post Q4 Earnings: What You Should Know
02:41pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
UnitedHealth Group's (UNH) fourth-quarter results are likely to reflect growing premiums, products and higher expenses.
Affimed Reports on Corporate Progress and Provides Regulatory Update for AFM13
11:30am, Monday, 09'th Jan 2023 GlobeNewswire Inc.
HEIDELBERG, Germany, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back th
Affimed Announces Approval of Clinical Trial Application in France for a Phase 1 Study of AFM28 in Relapsed/Refractory Acute Myeloid Leukemia
11:30am, Thursday, 22'nd Dec 2022 GlobeNewswire Inc.
HEIDELBERG, Germany, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back t
